Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results

Colorectal cancer (CRC) is one of the four major cancer sites, along with breast, lung and prostate (Siegel et al., 2013; Siegel et al., 2014a). It is estimated that approximately 1  in.20 people will develop CRC over their lifetime, although this number may be decreasing, indicating progress in CRC detection or prevention (Siegel et al., 2017; Siegel et al., 2014b). Approximately 65% of all patients developing CRC will survive 5 years after the diagnosis (Siegel et al., 2013 ; Siegel et al., 2014b), but this figure varies widely with the CRC stage at detection (Siegel et al., 2013; Siegel et al., 2014a).
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Source Type: research